Organization
University of Washington, Seattle, WA
5 abstracts
Abstract
Non-comparative, open-label, international, multicenter phase I/II study of nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with recurrent/metastatic Merkel cell carcinoma (MCC) (CheckMate 358).Org: Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, UCL Cancer Center, University College London, London, United Kingdom, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan,
Abstract
RNA-Seq based gene expression profiling of baseline and on-treatment breast tumors to predict response to HER2-directed therapy, without chemotherapy (TBCRC026).Org: Cancer Research @UCC, Cork, Ireland, Lineberger Comprehensive Center, Chapel Hill, NC, University of California, San Francisco, CA, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD,
Abstract
Historic redlining, modern neighborhood structures, and mortality in children, adolescents, and young adults with cancer.Org: University of Washington, Seattle, WA, University of California, San Francisco, San Francisco, CA, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, San Diego State University Department of Biology, San Diego, CA, Fred Hutchinson Cancer Center, Seattle, WA,
Abstract
TRICK-MCC: A proof-of-concept, investigator-initiated study of combination therapy with anti–PD-1, anti–LAG-3, and anti–TIM-3 in participants with advanced or metastatic PD-(L)1 refractory Merkel cell carcinoma.Org: University of Washington, Seattle, WA,
Abstract
A RETROSPECTIVE LOOK AT THE RECURRENCE OF DIGITAL ULCERS IN PATIENTS WITH SCLERODERMA AFTER DISCONTINUATION OF ORAL TREPROSTINIL Org: Division of Rheumatology, Johns Hopkins University, Baltimore, University of Michigan, Ann Arbor, MI, Cleveland Clinic, Cleveland, OH, Medical College of Wisconsin, Milwaukee, WI, University of Utah, Salt Lake City, UT,